SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-037953
Filing Date
2020-06-19
Accepted
2020-06-19 16:39:41
Documents
1
Period of Report
2020-06-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4234
  Complete submission text file 0001209191-20-037953.txt   5603
Mailing Address 1119 ST. PAUL STREET BALTIMORE MD 21202
Business Address
Nunn Jason Raleigh (Reporting) CIK: 0001444319 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35670 | Film No.: 20976140

Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 225 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 225 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Issuer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences